Genome-wide analysis of three positive histone methylation modifications controlled by SETD2 and menin inhibitors
To profile these three positive histone methylation modifications at the whole genome, ChIP-seq assay were performed in MOLM13 (MLL-AF9) after treatment with EZM0414 and Revumenib.
Authors
- 徐斌(Bin Xu)
Publication Details
- Journal
- China National GeneBank DataBase
- Published
- 2026-11-06
- DOI
- https://doi.org/10.26036/cnp0009431
- Primary Topic
- Chromatin Remodeling and Cancer
- Type
- article
- Field-Weighted Citation Impact
- 0.00